State of endocrine and immune systems in ovarian cancer patients and their role in antitumor resistance

被引：0
|
作者：
Vorobyova, LI [1 ]
Vinnitskaya, AB [1 ]
Yevtushenko, GV [1 ]
Svintsitsky, VS [1 ]
Mayevskaya, LP [1 ]
Bendyug, GD [1 ]
机构：
[1] MINIST PUBL HLTH UKRAINE,UKRAINIAN RES INST ONCOL & RADIOL,UA-252022 KIEV,UKRAINE
来源：
EXPERIMENTAL ONCOLOGY | 1997年 / 19卷 / 03期
关键词：
ovarian cancer; antitumor resistance; homeostasis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The results of investigation of some hormonal homeostatic indices and immunity of patients with disseminated ovarian cancer are given. Initial relative hyperestrogenization in these patients is detected. Effective complex treatment results in the improvement and normalization of hormonal homeostatic indices (increase of FSH, progesterone, essential decrease of prolactin). Data of the immunologic study testify to a significant inhibition of the immune system in ovarian cancer patients in administration of platidiam, these changes are less expressed in administration of polyplatillen.
引用
收藏
页码：242 / 245
页数：4
相关论文
共 50 条
  • [41] Plasma immune analytes in patients with epithelial ovarian cancer
    Block, Matthew S.
    Maurer, Matthew J.
    Goergen, Krista
    Kalli, Kimberly R.
    Erskine, Courtney L.
    Behrens, Marshall D.
    Oberg, Ann L.
    Knutson, Keith L.
    CYTOKINE, 2015, 73 (01) : 108 - 113
  • [42] Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance
    Ajina, Reham
    Malchiodi, Zoe X.
    Fitzgerald, Allison A.
    Zuo, Annie
    Wang, Shangzi
    Moussa, Maha
    Cooper, Connor J.
    Shen, Yue
    Johnson, Quentin R.
    Parks, Jerry M.
    Smith, Jeremy C.
    Catalfamo, Marta
    Fertig, Elana J.
    Jablonski, Sandra A.
    Weiner, Louis M.
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (04) : 386 - 400
  • [43] Cancer Immunology and Immunotherapies: Mechanisms That Affect Antitumor Immune Response and Treatment Resistance
    Zhao, Xianda
    Subramanian, Subbaya
    CANCERS, 2021, 13 (22)
  • [44] State of the Science: The role of HIPEC in the treatment of ovarian cancer
    Dellinger, Thanh H.
    Han, Ernest S.
    GYNECOLOGIC ONCOLOGY, 2021, 160 (02) : 364 - 368
  • [45] Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer
    Lorusso, Domenica
    Ceni, Valentina
    Muratore, Margherita
    Salutari, Vanda
    Nero, Camilla
    Pietragalla, Antonella
    Ciccarone, Francesca
    Carbone, Vittoria
    Daniele, Gennaro
    Scambia, Giovanni
    EXPERT OPINION ON EMERGING DRUGS, 2020, 25 (04) : 445 - 453
  • [46] Polyclonal antitumor immunoglobulin may play a role in ovarian cancer adjuvant therapy
    Tang, Lei
    Zhao, Xia
    MEDICAL HYPOTHESES, 2011, 76 (04) : 530 - 532
  • [47] The Role of endocrine G Protein-Coupled Receptors in Ovarian Cancer Progression
    Zhang, Qingyu
    Madden, Nadine Ellen
    Wong, Alice Sze Tsai
    Chow, Billy Kwok Chong
    Lee, Leo Tsz On
    FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [48] Endocrine response and resistance in breast cancer: A role for the transcription factor Fos
    Gee, JMW
    Willsher, PC
    Kenny, FS
    Robertson, JFR
    Pinder, SE
    Ellis, IO
    Nicholson, RI
    INTERNATIONAL JOURNAL OF CANCER, 1999, 84 (01) : 54 - 61
  • [49] Ovarian Cancer-associated Ascites Demonstrates Altered Immune Environment: Implications for Antitumor Immunity
    Giuntoli, Robert L., II
    Webb, Tonya J.
    Zoso, Alessia
    Rogers, Ophela
    Diaz-Montes, Teresa P.
    Bristow, Robert E.
    Oelke, Mathias
    ANTICANCER RESEARCH, 2009, 29 (08) : 2875 - 2884
  • [50] Role of p53 in drug resistance in ovarian cancer
    Shelling, AN
    LANCET, 1997, 349 (9054): : 744 - 745
12345